Key Developments: Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

4:01pm EDT
Price Change (% chg)

$-0.42 (-0.39%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Latest Key Developments (Source: Significant Developments)

Johnson & Johnson announces $5 bln share repurchase program
Monday, 21 Jul 2014 05:00pm EDT 

Johnson & Johnson:Approves the repurchase of up to $5 billion of the company's common stock.Repurchases may be made at management's discretion from time to time on the open market or through privately negotiated transactions.  Full Article

Johnson & Johnson announces quarterly dividend for third quarter 2014
Monday, 21 Jul 2014 11:10am EDT 

Johnson & Johnson:Declares cash dividend for third quarter of 2014 of $0.70 per share on the company's common stock.Dividend is payable on Sept. 09, 2014 to shareholders of record at the close of business on Aug. 26, 2014.Ex-dividend date is Aug. 22, 2014.  Full Article

Johnson & Johnson raises FY 2014 earnings guidance
Tuesday, 15 Jul 2014 07:45am EDT 

Johnson & Johnson:Increased FY 2014 earnings guidance to $5.85 - $5.92 per share.Says guidance excludes the impact of special items.FY 2014 EPS of $5.90 - Thomson Reuters I/B/E/S.  Full Article

Johnson & Johnson completes divestiture of Ortho-Clinical Diagnostics To The Carlyle Group
Monday, 30 Jun 2014 04:30pm EDT 

Johnson & Johnson:Completes divestiture of Ortho-Clinical Diagnostics business to Carlyle Group for about $4 bln, subject to customary adjustments.Under terms of the transaction, The Carlyle Group has acquired the Ortho-Clinical Diagnostics business, global provider of solutions for screening, diagnosing, monitoring and confirming diseases.  Full Article

Johnson & Johnson announces dividend increase of 6.1 pct
Thursday, 24 Apr 2014 10:22am EDT 

Johnson & Johnson:Declared a 6.1 pct increase in the quarterly dividend rate, from $0.66 per share to $0.70 per share.Payable on June 10 to shareholders of record at the close of business on May 27.Ex-dividend date is May 22.  Full Article

Johnson & Johnson raises FY 2014 guidance - conference Call
Tuesday, 15 Apr 2014 08:30am EDT 

Johnson & Johnson:Expects FY 2014 sales growth to range between 4.5 pct and 5.5 pct for a total expected level of reported sales between $74.5 billion to $75.3 billion, which is higher than previous guidance.Expects FY 2014 EPS, excluding special items, in the range between $5.80 and $5.90 per share or a growth rate of between 5 pct and 7 pct.This is higher than previous guidance.FY 2014 revenue of $74.3 million and EPS of $5.83 - Thomson Reuters I/B/E/S.  Full Article

Johnson & Johnson announces acceptance of binding offer from The Carlyle Group to acquire ortho-clinical diagnostics
Monday, 31 Mar 2014 07:45am EDT 

Johnson & Johnson:Accepts the binding offer from The Carlyle Group, which was received and announced on Jan. 16 to acquire its Ortho-Clinical Diagnostics business for about $4 bln.The transaction is expected to close toward the middle of the year, upon satisfaction of customary closing conditions.  Full Article

Maharashtra FDA cancels Johnson & Johnson's India’s licence-Business Standard
Thursday, 20 Mar 2014 02:34pm EDT 

Johnson & Johnson:The Maharashtra’s Food and Drug Administration (FDA) has scrapped Johnson & Johnson India’s licence to make cosmetics at its unit in Mulund, a Mumbai suburb-Business Standard.The order was issued by the joint commissioner on March 15 while giving time till April 21 to appeal the decision.The company has been held responsible for the violation of the Drugs & Cosmetic Act and the rules framed in 1945.A J&J India spokesman said, 'It is inappropriate to comment since the matter is sub judice.  Full Article

Reckitt Benckiser Group Plc to acquire global rights to K-Y brand from Johnson & Johnson subsidiary, McNEIL-PPC Inc
Monday, 10 Mar 2014 04:20am EDT 

Reckitt Benckiser Group Plc:Signs definitive agreement to acquire the global rights to the K-Y brand from McNEIL-PPC Inc, a subsidiary of Johnson & Johnson.Transaction is expected to close in mid 2014.No employees or fixed assets are included in the purchase.  Full Article

Louisiana's court rules for Johnson & Johnson in appeal of Risperdal suit - Reuters
Tuesday, 28 Jan 2014 04:52pm EST 

Johnson & Johnson:won an appeal in Louisiana Supreme Court on Jan. 28 over its marketing of anti-psychotic drug Risperdal as the court overturned a ruling that would have imposed a $258 million penalty on the company - Reuters.The ruling said that the Louisiana Attorney General, James Caldwell, failed to prove that Janssen Pharmaceutical Inc, part of J&J, violated state law when it misrepresented through off-label statements the potential risk of side effects of the drug.The Louisiana case was not part of a broader $2.2 billion settlement that J&J had made last fall with the U.S. Department of Justice regarding marketing practices for the drug.  Full Article


Coke, J&J join big companies behind new employee wellness push

WASHINGTON - Leaders of some of the biggest U.S. corporations, from Coca-Cola Co to Johnson & Johnson , unveiled a campaign on Tuesday to reduce the nation's healthcare costs, urging their peers to embrace wellness programs to improve employee health.

Search Stocks